The further work required to establish sphingolipids as a biomarker of prediabetes risk is discussed by Dr Samuel Dagogo-Jack (University of Tennessee Health Science Center, Memphis, TN, USA).
The abstract ‘Association of Ceramide and Sphingolipid Species with Incident Prediabetes among Offspring of Parents with Type 2 Diabetes’ was presented at the 82nd American Diabetes Association Scientific Session, June 3-7, 2022.
Questions:
- What needs to be done to establish sphingolipids as a biomarker of prediabetes risk? (0:40)
- What are the next steps in your research? (4:18)
Disclosures: Samuel Dagogo-Jack has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ADA 2022.
